Skip to main content

Published locations for Dupilumab maintains efficacy despite dose reduction in persistently-controlled atopic dermatitis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Dupilumab maintains efficacy despite dose reduction in persistently-controlled atopic dermatitis

User login

  • Reset your password
  • /content/dupilumab-maintains-efficacy-despite-dose-reduction-persistently-controlled-atopic
  • /dermatology/article/264924/atopic-dermatitis/dupilumab-maintains-efficacy-despite-dose-reduction